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Abstract
Mammalian neural circuits are sophisticated biological systems that choreograph behavioral
processes vital for survival. While the inherent complexity of discrete neural circuits has proven
difficult to decipher, many parallel methodological developments promise to help delineate the
function and connectivity of molecularly defined neural circuits. Here, we review recent
technological advances designed to precisely monitor and manipulate neural circuit activity. We
propose a holistic, multifaceted approach for unraveling how behavioral states are manifested
through the cooperative interactions between discrete neurocircuit elements.
Introduction
“Can the brain understand the brain? Is it a giant computer, or some other kind of
giant machine, or something more? The brain is a tissue. It is a complicated,
intricately woven tissue, like nothing else we know of in the universe, but it is
composed of cells, as any tissue is. They are, to be sure, highly specialized cells,
but they function according to the laws that govern any other cells. Their electrical
and chemical signals can be detected, recorded and interpreted and their chemicals
can be identified; the connections that constitute the brain's woven feltwork can be
mapped. In short, the brain can be studied, just as the kidney can.”
— David H. Hubel, Scientific American 1979
This thought-provoking quote from the Nobel prizewinning neurophysiologist David Hubel
(1926–2013) highlights how the architecture and function of the brain is exceptionally
complex, but also suggests that this intricate biological system can be dissected with the
right strategy and techniques. The need to map the connectivity and activity of precise
neurocircuits is becoming ever stronger as the toll exacted by neurological and
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neuropsychiatric disorders on society increases, and given the current goals set forth by
large-scale research endeavors such as the NIH Brain Research through Advancing
Innovative Neurotechnologies (BRAIN) Initiative. Recent developments in neurotechnology
will likely assist in achieving these goals.
In this review, we shall discuss the new toolsets that are being developed to study neural
circuit function, such as optogenetic techniques and in vivo measurement strategies, and
explain how a combinatorial approach can be taken to systematically characterize the
connectivity, function, and neurophysiological dynamics of precise neural circuits during or
following discrete behavioral states. Collectively, assembling a genetically precise neural
circuit wiring diagram and unraveling the choreography of neuronal network dynamics
within a defined neurocircuit with advanced in vivo measurements and manipulations should
provide critical insights into how neuronal networks orchestrate behavioral states.
The Neurophysiological Dynamics of Distinct Neurocircuits
The ability to identify single-unit activity originating from genetically defined neurons
provides an avenue for elucidating how specific neuronal subpopulations are engaged by
environmental stimuli [1–5]. Without these genetically guided electrophysiological
approaches, the readout from extracellular recordings within brain tissue that originates from
a vast array of diverse cell types, oftentimes with their own unique function, makes it
virtually impossible to definitively characterize the activity patterns of select neuronal
subpopulations. As extracellular recordings within a given brain region usually reveal a
multitude of discrete firing profiles time-locked to behaviorally relevant stimuli, it is now
critical to determine if these functionally distinct activity patterns arise from genetically
distinct neuronal subpopulations. Identifying distinct activity patterns will likely be
fundamental for illustrating how whole neurocircuit systems are equal to the sum of their
individual parts (genetically and functionally distinct cell types).
In order to distinguish the firing profiles of genetically defined neuronal populations, a Cre
recombinase-dependent viral vector encoding the light-activated cation channel,
channelrhodopsin-2 (ChR2), can be introduced to genetically distinct neuronal populations
in various Cre-driver transgenic mouse lines [6–9] (Figure 1A; Table 1). Additional
recombinases, such as Flp or Dre, can also be used to generate cell-type specific expression
of ChR2, and they can be combined with Cre-dependent targeting strategies to isolate
genetically separate subpopulations within the same subject [10]. The number of available
transgenic mouse lines is rapidly increasing, and they have become readily available from
the Allen Brain Institute for Brain Science, GENSAT, Jackson Laboratory, and independent
laboratories.
While genetically guided tools offer cell-type specificity, region-specific targeting of ChR2,
via localized delivery of a ubiquitous viral vector (using human synapsin [11] or CAG
[12,13] promoters), provides anatomical specificity (Table 1). Spatial targeting of ChR2 to a
discrete brain region can reveal global information about how a neurosubstrate encodes
certain behavioral states [14]. Integrating genetic- and region-specific targeting strategies is
a powerful way of acquiring cell-type and spatial resolution; however, neighboring brain
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regions can be similar in their cytoarchitecture, gene expression patterns, and connectivity
[15], making it difficult to isolate the unique function of a region. Furthermore, the spread of
viral particles is difficult to control, even when small-volume viral microinjections are
employed, and can result in superfluous transduction of regions surrounding the target area.
For these reasons, the initial experimental design should involve the investigation of
surrounding regions that are prone to infection and subsequent contamination of data
analysis. Improvements in viral delivery methods are needed for completely restricting
circuit analysis to specific cell types in discrete brain regions that are situated in
homogenous zones of tissue.
When extracellular recordings are performed, ChR2 can be a useful physiological tag or
marker, as a brief pulse of blue light elicits a short-latency action potential in cells
expressing ChR2 that is reliably detected across multiple light presentations (Figure 1B,C)
[4,16,17]. Consequently, cells expressing ChR2 are distinguishable from ‘ChR2-negative’
neurons during in vivo extracellular recordings based on their electrical responses to light.
Under certain circumstances, however, using phototagging methods to identify light-
responsive neurons may generate false-negatives or false-positives. For example, some
light-evoked responses may be mediated through both local and distal polysynaptic circuit
modulation, as photoexcitable ChR2-expressing neurons may respond to light and elicit
detectable spikes from neighboring synaptic partner neurons that do not express ChR2, thus
giving a false-positive. When trying to identify neurons in vivo, there are certain criteria that
can be used to minimize such problems. First, demonstrate a high-spike fidelity in response
to high photostimulation frequencies [1,2]. Second, detected units possess short light-evoked
latencies that have minimal variance (spike jitter) [1,2,5]. Third, light delivery at certain
intensities should not alter the shape of the detected waveform, indicating that the responses
to light are not caused from direct photoelectric artifacts [1,2].
While these criteria may uphold for particular cell types, other cells of interest may require
adjustments or alternative criteria for properly identifying light responses. False-negative
occurrences are influenced by factors underlying the detectability of light responses in
recorded neurons. The detectability of light-responsive neurons depends on the level of
ChR2 expression and on the volume of tissue that is efficiently illuminated by light. ChR2
expression strength is contingent upon the diffusion and spread of viral particles as well as
the viral titer, while the volume of illuminated tissue relies on the intensity and scattering of
the light in tissue. Thus, the absence of light-evoked responses does not completely rule out
the possibility that a recorded neuron expresses the target gene.
The functional role of particular neurons depends on how they are integrated within a
circuit. Thus, specific neuronal subpopulations that project to different postsynaptic target
regions often display unique firing patterns compared to cells that project elsewhere.
Therefore, phototagging of genetically defined neurons in a projection-specific fashion can
further define and refine the computational role of participant cells within a complex circuit
[2]. To accomplish this, ChR2 localized in axons and presynaptic terminals is activated via
light delivery through implanted optical fibers. Congruently, multielectrode recording
devices are implanted near the somas of these ChR2-targeted neurons (Figure 1D,E).
Photostimulation of ChR2-expressing axonal fibers elicits an antidromic spike that
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propagates from the axons back to the soma region where the implanted electrode is capable
of detecting these antidromic-initiated spikes (Figure 1E,F). To confirm that detected light-
evoked spikes originate from antidromic action potentials, orthodromic and antidromic
photostimulations that occur close in time can be used to demonstrate that the photoinitiated
spikes, traveling in opposite directions, collide with each other and occlude the detectable
spike. Spike collision is a key indicator that the action potentials are conducting along the
same axon and thus are not due to synaptic transmission within a polysynaptic circuit
[2,18,19]. Because ChR2 is expressed along axons, in certain situations the photoinitiation
site of the antidromic spike is not restricted to the terminals and may arise from
photoactivated fibers of passage that traverse through the postsynaptic target region. This
key factor should be kept in mind when antidromic photostimulation methods are used to
identify projection-specific activity.
Current developments in high performance in vivo extracellular recording equipment along
with the advances in light sources have significantly facilitated the application and
versatility of electrophysiological phototagging methods. Compared to other light sources
(lasers), light-emitting diodes (LEDs) offer stable light output, have exceptionally long
lifetimes, and are cost efficient. Thus, independent research labs are implementing LED
based systems with electrophysiological devices; for instance, the design of wireless micro-
LED devices that are incorporated with electrophysiological sensors permit the ability to
control and monitor the activity of circuit elements during complex behavioral tasks [20].
Furthermore, the construction of optrode devices that allow for simultaneous
electrophysiological recording and optical stimulation [21], as well as the fabrication of an
array of thin microwaveguides that delivers light in a three-dimensional pattern throughout
the brain [22], have also extended the ability to precisely monitor and manipulate neural
circuit activity.
While in vivo extracellular recordings can produce valuable neurophysiological information
in a precise temporal fashion, there are many challenges faced with this technique that can
drastically hinder the investigation of neurocircuit dynamics. The poor spatial resolution
(∼100 mm) of multielectrode arrays [23] results in a low yield of detectable light-responsive
units and thus limits the ability to record the neural activity from a large ensemble of
neurons. For example, the small sample size obtained from extracellular recordings may not
accurately represent the activity of the larger discrete neuronal population, as minor but
important, subpopulations may exist within the larger genetically defined network, leading
to a plethora of various firing patterns to go unnoticed. The long-term performance of
multielectrode arrays for chronic in vivo recordings can often diminish over time because of
obstruction from scar tissue (gliosis), protein fouling, and increased electrode impedance
[24–26]. And the instability of the recording device in tissue prevents the unequivocal
isolation of the same unitary signal on the same electrode across multiple recording sessions
[27]. This limitation in particular may greatly reduce insight into neural circuit function
achieved by single unit recordings, as the activity patterns of unequivocally the same neuron
cannot be observed over chronic time scales (days to months), where neuronal networks
may adapt in response to stimuli or environmental demands. In vivo imaging of neuronal
activity provides a complementary strategy to electrophysiological phototagging methods by
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defining the activity patterns of distinct participant neurons within a circuit over longer time
scales.
Modifications that have been made to long-term in vivo imaging techniques [28], along with
the advent of newer variants of genetically encoded calcium indicators [29,30], have
partially alleviated some of the limiting factors of extracellular recordings by resolving the
activity from large genetically-defined neuronal populations over extended timescales [31–
34]. Given that calcium ions (Ca2+) enter the cell in response to neuronal activation [35],
and that engineered fluorescent proteins display changes in fluorescent intensity as they bind
Ca2+ [36], action potentials and synaptic transmission are reliably measured by imaging
changes in intracellular free Ca2+ [37]. Chen et al. [30] recently developed a family of
ultrasensitive protein calcium sensors (GCaMP6.0) that allow for reliable detection of single
action potentials in neuronal somata during in vivo two-photon imaging. Furthermore, two-
photon imaging of GCaMP6-expressing neurons permits detection of synaptic calcium
signaling within individual dendritic spines over several months (Table 2) [30].
Future additions to the color range of calcium indicator proteins [38], such as red fluorescent
calcium indicators (RCaMP), will further improve the imaging depth within intact brain
tissue, since near-infrared light, containing longer wavelengths, scatters less through
biological tissue (Table 2) [39]. Additionally, chromatic variants allow for simultaneous
multi-color activity imaging of multiple genetically distinct neuronal populations. As
calcium transients can be detected in specific presynaptic terminals [40], these new
engineered sets of chromatic variants may be utilized to simultaneously monitor the in vivo
responses of a genetically defined postsynaptic neuron together with its presynaptic axon
terminal input to reveal the precise mechanism by which information is transmitted and
integrated between distinct cells within a circuit during a particular behavioral state (Figure
2A). Color-shifted indicators enable the integration of optogenetic neuronal activation and
silencing manipulations with functional in vivo calcium imaging to control and monitor
concurrently specific circuit interactions or connections [38]. This integration will enable a
biofeedback mechanism for controlling neurocircuit activity by allowing the natural circuit
dynamics to direct the optogenetic manipulation parameters during behavioral tasks —
frequency, duration, and the precise time point of stimulation or inhibition — instead of
relying on the artificial control that is typically employed by the experimenter. The
information provided by these types of experiments could inform future human applications
that involve a biofeedback system paired with deep-brain stimulation.
Two-photon imaging in head-fixed, awake behaving rodents permits the detection of Ca2+
associated activity in neural circuits [41,42] and makes possible long-term imaging with the
application of non-invasive thinned-skull cranial window techniques [43]. The behavioral
readouts from such experiments are limited, however, as the animals are unable to freely
move during two-photon imaging (Figure 2B). Innovative virtual-reality systems that use
linear or spherical treadmills and simulated environments in head-restrained mice [31,44], as
well as voluntary head restraint methods that involve operant conditioning systems [45],
help increase the complexity of behavioral tasks during two-photon imaging.
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The optical-fiber based approaches [34,46,47] that are being developed are better suited for
more complicated freely moving behavioral experiments that require in vivo imaging of
activity in large neuronal populations situated in deep brain regions. Microendoscopes are
composed of a relay lens with a gradient-index (GRIN) lens attached at the bottom. Because
GRIN lenses have a flat optical surface to refract light through a refractive index gradient,
they can efficiently focus and collect light through highly scattered tissue in deep brain
regions [48] (Figure 2C). High-speed, miniature epi-fluorescence microscopes (weighing
less than 2 g) equipped with a complementary metal oxide semiconductor (CMOS) image
sensor and interfaced with a microendoscope are able to resolve simultaneous Ca2+ signals
in approximately 1,000 neurons in the hippocampus per freely behaving mouse. Notably,
these integrated microscopes can repeatedly image neuronal populations for weeks to
months [34] (Figure 2D). Further technical developments, including innovative new
microendoscopic methods and Ca2+ indicators, will likely prove to be pivotal for addressing
how large ensembles of genetically defined neurons encode aspects of multifaceted
behavioral tasks.
Cataloging the Connectivity and Function of Distinct Neural Circuits
Unraveling the intricate neural wiring patterns within molecularly defined circuits is
essential for elucidating the anatomical specificity underlying particular behavioral states.
While gross neuroanatomical tracing methods have been used since the dawn of modern
neuroscience to provide critical insight into the axonal wiring between brain regions, these
classical strategies typically cannot delineate neural circuit connectivity originating from
‘genetically’ distinct neuronal populations (that is, populations differing in their states of
gene expression). Anterograde tracing viruses, such as Adeno-associated viruses (AAVs)
[49] encoding a channelrhodopsin tagged with a fluorescent protein (ChR2-eYFP), are
useful for mapping specific axonal projections and their selective destination points within
distinct brain regions. AAV-mediated delivery of ChR2-eYFP to projection neurons in one
brain region results in somata transduction [50,51] and subsequently leads to anterograde
transfer of the membrane-bound fusion protein to the axon terminals in downstream regions
[52–54], allowing anatomical visualization of the pattern and density of innervation (Figure
3A). However, these AAV-based anterograde tracing strategies cannot exclusively identify
functional connections between multiple circuit nodes and so should only be used as an
initial guide for visualizing possible neurocircuit interactions.
Transsynaptic viral tracers can be used to identify putative synaptic partner neurons between
multiple brain regions. Wheat germ agglutinin (WGA) [55,56] is a transsynaptic tracer
protein that is efficiently taken into neurons and transported anterogradely and retrogradely
to axons and dendrites (Figure 3B). Thus, AAV-based constructs containing WGA transgene
products label both first-order neurons (starter neurons) and second-order downstream
neurons [57,58] (Table 3). While this neuroanatomical tracing tool can uncover
multisynaptic neural pathways, both anterograde and retrograde traversing of synapses make
it difficult to analyze the directionality and specificity of a particular circuit [57]. Other viral
tracers, such as Herpes simplex viruses (HSV) [59–62] and Vesicular stomatitis viruses
(VSV) [63] can be used to achieve greater anatomical specificity, as they can travel in a
unidirectional manner (Table 3).
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Axonal terminal targeting with retrograde transsynaptic viruses can be used to determine the
specific connections between postsynaptic seed neurons and their upstream presynaptic
input cells. The Pseudorabies (PRV) and Rabies viruses (RABV) are well characterized and
serve as effective transneuronal tracers of multisynaptic circuit connections [64,65] (Table
3). Given that any particular brain region contains a multitude of cell types and connections
with other structures, and that the fast rate of retrograde viral spread increases the number of
synaptic phases, it becomes increasingly challenging to decipher the precise wiring from the
initial viral infection site [66]. Thus, the ideal tracing scenario would involve targeting
genetically defined postsynaptic starter neurons and their monosynaptic inputs with a
transsynaptic retrograde tracer.
Wickersham et al. [67] made this possible by developing a modified monosynaptic rabies
virus, EnvA-SADΔG-GFP, which restricts viral infection to a genetically distinct
postsynaptic cell type and its monosynaptic input cell (Figure 3C). Under normal
circumstances the modified rabies virus does not infect mammalian tissue, but infection will
occur in the presence of the envelope glycoprotein of avian sarcoma/leukosis (EnvA)
receptor, TVA. Thus, postsynaptic target neurons must express TVA for initial rabies
infection, as well as the rabies glycoprotein (RG) for the formation of new viral particles and
transsynaptic spread. Cre-dependent viral delivery of TVA and RG along with the infusion
of the modified rabies virus sufficiently labels presynaptic neurons with GFP from a single
postsynaptic seed neuron [68–70] (Table 3). This viral construct enables specific presynaptic
neurons to be targeted with many new rabies virus variants to perturb and record activity
from discrete circuit connections. Some of these variants encode ChR2 for photostimulating
specific presynaptic neurons and GCaMP for imaging Ca2+ activity in discrete upstream
regions [71].
The further development newer variants could expand the utility of transsynaptic tracing
tools by implementing the viruses as functional modulators and/or neural activity monitors,
thereby making these tools more than just an anatomical visual guide. Despite the utility of
these viral tracing tools for circuit mapping, complementary approaches, such as ChR2-
assisted slice electrophysiology experiments, should be used in combination to validate the
presence of a functional synaptic connection between virally identified circuits. Another
important factor to consider when applying these viral tracing techniques is the complexity
and diversity of various synaptic connections that may display differences in transsynaptic
viral spread. Accordingly, the absence of viral labeling does not exclusively rule out a
specific circuit connection.
Mapping circuits with neuroanatomical viral tracers and molecular labeling with
immunohistochemical techniques can generate large volumes of data, and information from
an intact brain may be required to interpret that data set and allow the accurate and efficient
reconstruction of the architecture of a specific neurocircuit. Traditionally, sectioning and
reconstruction [72] of an intact system have been used for mapping connections between
populations of neurons, but these methods are tremendously time consuming and do not
preserve the structural integrity of an intact circuit. Moreover, because of the limitations of
working with biological tissues, large volumes of tissue (∼300–400 mm thick) drastically
reduce imaging resolution even with two-photon applications [73], further compounding the
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difficulty of rendering detailed three-dimensional information from an intact biological
system. Therefore, reducing the opacity of brain samples (increasing tissue transparency)
and minimizing the amount of scattered light through deep brain areas to increase the
imaging depth of undivided biological systems are major priorities for improving the image
acquisition of fluorescent labeled neurocircuits.
Recent optical clearing methods, for example using the urea containing Scale clearing agent,
enable deep tissue imaging of fluorophores, but they require long incubation periods
(months) and sacrifice the integrity of the sample via tissue swelling and expansion [74]. In
contrast, a water-based optical clearing agent that utilizes different concentrations of
fructose, See Deep Brain (SeeDB), reduces the incubation period to a few days and
preserves the original morphology at the cellular resolution [75]. This method, however,
appears to work best with smaller sample sizes and may not be suitable for completely
clearing whole adult rodent brains.
A pioneering clearing method that shows promise for obtaining and maintaining fine
biomolecular details in whole brains is ‘Clear Lipid-exchanged Acrylamide-hybridized
Rigid Imaging/Immunostaining/In situhybridization-compatible Tissue-hydrogel’,
conveniently known as CLARITY [76]. CLARITY operates through the removal of lipid
membranes, while retaining biomolecules to preserve the structural integrity. First, the tissue
is transformed into a nanoporous hydrogel-hybridized structure to support the sample and to
prevent anatomical deformation. This hydrogel-support system allows for the removal of
lipids that are responsible for the light-scattering properties of brain tissue, thereby making
the tissue more transparent following electrophoretic-clearing procedures (Figure 4A). In
addition, the electrophoretic-clearing technology permits multiple rounds of antibody
staining and de-staining in whole intact tissue samples (Figure 4B). Passive diffusion (∼1 to
2 week incubation period) of the sodium dodecyl sulfate (SDS)-boric acid clearing solution
without electrophoresis can also be applied to efficiently clear thick slices of tissue (500 mm
to 1 mm). Future optical clearing applications may consider combining SeeDB and
CLARITY methods to optimize tissue transparency.
The major caveat with these optical clearing strategies is the ability to acquire and analyze
detailed biological information at the cellular resolution with a fast volumetric imaging
system. Two-photon systems are ideal for imaging deep in tissue, but the limited focal plane
of the microscope yields time-consuming tile scans for large volumetric samples (Figure
4C). Laser-scanning light-sheet microscopy [77] is suitable for achieving high-speed
volumetric imaging and for obtaining high-resolution features at the cellular level [78]
(Figure 4D). Ultimately, both microscope systems require the proper objectives that possess
a long working distance and a refractive index that matches the clearing solution in order to
efficiently image large volumetric cleared tissue samples.
Manipulating neurons to control behavioral responses has been a hallmark feature of
neuroscience [79–82]. The brain, however, embodies a mosaic of diverse cell types that are
exquisitely woven together; thus, manipulations involving non-specific electrical stimulation
are not sufficient for ascribing brain function to behavior. The functional role of different
cell types can be defined by their genetic complexion; therefore, genetically directed
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manipulations are vital for understanding the causal link between specific circuit function
and mammalian behavior. Advances in molecular genetics and genetically guided activity
modulators have provided entry points to identifying precise neurocircuits that modulate the
intensity and direction of certain behaviors. To selectively target genetically defined
neuronal populations, as described previously, Cre recombinase in transgenic animals can be
used to selectively turn on gene expression for Cre-dependent viral vectors encoding
optogenetic or chemogenetic modulators [83] for activating (ChR2) and silencing neurons
(archaerhodopsin (eArch3.0)) [9,84–90] (Figure 5A,B). Additions to the microbial opsin
toolsets and the growing availability of Cre-driver lines are rapidly driving the ability to
optically control activity in genetically distinct neuronal populations. In addition, new
genetically encoded activators utilize radio frequencies to activate neurons by allowing
calcium influx through the opening of temperature-sensitive ion channels [91], which may
prove useful for translational and less-invasive applications. Although gene expression
targets are viable tactics for isolating discrete processes within a circuit, functional
heterogeneity within a genetically distinct network may mask the precise role of certain
brain regions in regulating behavior.
Targeting subsets of neurons based on their activity is advantageous for isolating discrete
functional processes within a circuit. Hence, particular behavioral processes involved with
specific memories and sensory representations are regulated by sparse neurons that may
share genetic similarity with other local neurons that are not involved with these behaviors.
Therefore, activity-dependent expression of optogenetic manipulators would allow restricted
reactivation of only the subset of neurons that had been activated by a previous behavioral
experience [92]. To accomplish this, Fos, an immediate-early gene that is a marker for
neuronal activity [93], is used as a promoter to drive ChR2 expression in neurons activated
by discrete behavioral episodes [94]. These naturally activated neural ensembles can be
subsequently reactivated artificially to simulate the previous experience [95,96]. Targeting
functionally defined neuronal ensembles will advance our understanding of the causal
relationship between environmentally induced neural firing patterns and complex cognitive
processes, such as learning and memory. However, improving the poor temporal resolution
of Fos expression by utilizing other markers of neuronal activation will likely be important
for expanding upon the specificity of behavioral mimicry experiments. Ultimately, the
functional significance of a given circuit should be dissected not only by its genetic
complexion, but also by its activity and connectivity. Therefore, a combinatorial approach
should syndicate all of these neuronal targeting strategies to properly decipher the precise
neural codes of behavior.
Although optogenetic manipulations offer precise temporal control of neural circuit activity,
the propensity of decreased opsin efficiency and phototoxicity significantly increases during
chronic behavioral manipulations. Thus, behavioral experiments that demand sustained
neuronal modulation may consider using 'designer receptors exclusively activated by
designed drugs, or DREADDs [83,97]. DREADD methods utilize a pharmacologically inert
compound, clozapine-N-oxide (CNO), that potently activates a family of muscarinic
receptors on a longer timescale (up to several hours), allowing for selective modulation of
signal-transduction pathways that is sustained through long durations [98]. In comparison to
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the properties of optogenetic manipulators, longer-term chemogenetic approaches have the
capacity to induce prolonged hyperpolarization and depolarization effects in genetically
defined neuronal populations [6,99–101], making it a more viable option for reproducing the
natural physiological characteristics of particular behavioral/disease states that are
associated with persistent hyper- or hypo-activated neural circuits.
Concluding Remarks
The current renaissance in systems neuroscience has been fueled by innovative technologies
that can synergistically be applied to dissect neural circuit function. These collaborative
approaches will continue to transform our understanding of the function of genetically
defined neural circuits. While the neurotechnology described here opens the door to
experimentation that would have been considered in the realm of science fiction a decade
ago, the possibility exists that unforeseen limitations with these approaches will arise as they
are more widely adopted. Thus, continued refinement of these tactics and scientific vigilance
are critical to ensure these methods do not produce erroneous discoveries. Collectively,
these tools will help generate a holistic understanding of circuit-wide function that underlies
behavioral processes.
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Phototagging neuronal populations based on their genetic identity and projection targets
during in vivo electrophysiological recordings.
(A) Microinfusion of virally encoded ChR2-eYFP into a particular brain region isolates
genetically defined neuronal subpopulations for optogenetic identification. (B)
Multielectrode array is coupled to an optical fiber and implanted within the viral-targeted
brain region to detect orthodromic elicited spikes. (C) Somata photostimulation via blue
light delivery from an optical fiber evokes detectable orthodromic spikes at the tip of each
electrode wire. (D) Virally encoded ChR2-eYFP is introduced to the presynaptic brain
region, allowing the fused protein to traffic down to the axonal terminals within the
postsynaptic brain region. (E) Optical fiber is inserted directly above the postsynaptic region
to photoactivate the ChR2-expressing presynaptic fibers, while the multielectrode array is
implanted in the presynaptic region to record the antidromic elicited spikes originating from
the terminals within the postsynaptic target region. (F) Terminal photostimulation elicits a
back propagating action potential (antidromic spike) that is detected near the cell bodies of
the presynaptic region where the multielectrode array is located.
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In vivo calcium imaging using genetically encoded indicators reveals discrete neuronal
network activity.
(A) Microinfusion of virally-encoded RCaMP (red) into the postsynaptic region allows two-
photon imaging of somata calcium activity. In parallel, virally-encoded GCaMP (green) is
targeted to the presynaptic input neurons, enabling simultaneous imaging of terminal
calcium activity. (B) Schematic illustrating in vivo somata calcium imaging with a two-
photon microscope in a head fixed mouse. (C) Configuration for calcium imaging in freely
behaving mice using mini epi-fluorescent microscopes that are equipped with
microendoscopes. (D) Illustration of microendoscopes that can detect calcium signals from
GCaMP6.0-expressing cells during complex behavioral tasks.
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Virally encoded neuronal tracing of genetically defined neuronal populations.
(A) Schematic outlining viral targeting of ChR2-eYFP (top) and a confocal image showing
ChR2-eYFP labeling of axon projections (bottom). (B) Diagrams for anterograde
multisynaptic viral tracing using WGA. (C) Timeline and schematic for modified rabies
virus tracing. Cre-expressing neurons (red) are first infected with TVA and RG (left)
allowing subsequent monosynaptic retrograde viral spread of rabies virus to presynaptic
input neurons (green; right).
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Clearing tissue for imaging intact neural circuits.
(A) Diagram for electrophoresis clearing of hydrogel-hybridized tissue. (B) Multiple rounds
of immunostaining in cleared whole brains. (C) Configuration for high-speed light sheet
imaging of intact neural circuits in cleared tissue. (D) Two-photon imaging of neuronal
populations in a cleared whole brain.
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In vivo optogenetic manipulations of genetically distinct neurons during behavioral
measurements.
(A) Somata photostimulation of genetically defined neuronal populations during a
behavioral task. (B) Somata photoinhibition of genetically distinct neuronal populations
during a behavioral task.
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Table 1
Commonly used viral constructs for optogenetic and chemogenetic experimentation.
Manipulators Targeting method Function References
hSyn-ChR2, Ubiquitous spatial targeting of a brain region Elucidating regional and projection-specific function [11]
CAG-ChR2 [12,13]




Ef1α-DIO- eArch3.0 Cre-dependent: cell-type specific Photoinhibition for behavioral manipulations [89,90]
Ef1α-DIO-hM3Dq Cre-dependent: cell-type specific DREADD receptor: long-term neuronal excitation [98–100]
Ef1α-DIO-hM3Di Cre-dependent: cell-type specific DREADD receptor: long-term neuronal inhibition [6,98–100]
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Table 2
Commonly used genetically encoded calcium indicators for reporting neural activity.
Calcium indicators λabs (2-P), nm Function References
GCaMP6 940 Imaging somata, dendritic and axonal calcium activity [30]
RCaMP 1070 Imaging somata calcium activity with ChR2 manipulations [38]






















Jennings and Stuber Page 23
Table 3
Genetically encoded viral tracers.
Tracers Targeting method Function References
VSVΔG (LCMV-G), rVSV(RABV-G) Ubiquitous spatial targeting of a brain
region
Monosynaptic and polysynaptic
anterograde and retrograde tracers
[63]





PRV, RABV Ubiquitous spatial targeting of a brain
region
Transneuronal retrograde tracers [64,65]
EnvA-SADΔG Cre-dependent: cell-type specific Monosynaptic retrograde tracers [67–70]
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